Publications from TDC and Clinical Epidemiology authors: Latest results from PubMed
URL:
Updated: 4 hours 50 min ago
CONCLUSIONS: An evaluation of pharmacovigilance data from 2 different sources revealed no evidence of greater proportional reporting for neurological AEs specific to the use of eprinomectin-containing products in cats than for other MLs or emodepside.
